The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease ...

COPD (Chronic Obstructive Pulmonary Disease) is a lung disease that causes breathing difficulties, chronic cough, and mucus.

After a delay, the FDA has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately ...

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with ...

Lung disease affects around 1 in 7 older persons, making it a serious health risk. Among persons 60 years of age and older, ...

Cirrhosis is one of the leading causes of mortality from non-communicable diseases, with complications arising as liver ...

Dupixent approved in China as the first-ever biologic medicine for patients with COPDApproval follows EU approval of Dupixent for adults with ...

Eric Borstein is known as “The Walking Man,” and for good reason. He has Pulmonary Arterial Hypertension, a rare incurable ...

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...

WASHINGTON – Industry stakeholders are concerned that a recommendation to require COPD patients to try and fail on ...